Guru Ownership Trend
Guru Analysis for Enliven Therapeutics, Inc. (ELVN)
Enliven Therapeutics, Inc. (ELVN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.36 M.
Top institutional holders include Paul Tudor Jones.
Institutional sentiment is currently Bullish. This is evidenced by a $2.04 M net inflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Enliven Therapeutics, Inc. (ELVN)
Major holders include Paul Tudor Jones ($2.04 M). According to the latest reported data, 1 tracked investment managers collectively hold approximately 40,118 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.04 M, with 1 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in ELVN during the most recent reporting period.
Yes, 1 managers opened new positions in ELVN, and 0 increased their existing holdings. The total reported buy value was $2.04 M.